Oura, the smart-ring maker that helped popularize sleep-and-recovery tracking, launched its fifth-generation ring in late May 2026 alongside a wave of AI features that push the device toward broader metabolic and cardiovascular monitoring. Preorders opened May 28, 2026, with shipping beginning June 4, according to Forbes and the company’s own announcements.
Smaller ring, bigger feature set
The Oura Ring 5 is roughly 40 percent smaller than earlier generations, with thickness cut from 3.5mm to 2.8mm and width reduced from 7.9mm to 6mm, built from nonallergenic titanium and rated for about a week of battery life per charge. Base finishes (Silver and Black) start at $399, with premium finishes such as Gold, Deep Rose, and Stealth priced at $499; membership remains a separate subscription at $5.99 a month or $69.99 a year, on top of the hardware cost.
Health Radar and AI-driven monitoring
The headline software feature is Health Radar, developed with more than 40 in-house physicians and researchers, which adds proactive blood pressure trend monitoring and nighttime breathing analysis layered on top of Oura’s existing temperature and heart-rate sensing. The company also introduced GLP-1 Insights, aimed at users on weight-loss medications who want to track how the drugs affect sleep, recovery, and activity patterns, and Oura Health Records, a tool for organizing chronic-condition data over time.
AI meal tracking draws mixed reactions
Alongside Ring 5, Oura rolled out AI-powered meal and metabolism tracking that lets users log food and receive automated nutritional breakdowns tied to their glucose-adjacent readings and daily scores. Tom’s Guide, reviewing the rollout, flagged concerns that pairing an AI diet feature with a device already known for obsessive self-quantification could feed unhealthy tracking habits for some users, even as the feature is marketed as a convenience for casual dieters. Oura has also partnered with telehealth provider Counsel Health to let members get AI-assisted medical guidance validated by licensed clinicians, available in 43 states at launch — a feature that stops short of diagnosis but goes further than most wearables in connecting data to actionable medical advice.
Context: a crowded, fast-moving category
Oura’s update lands the same season Whoop expanded its own AI coaching and clinician access, Samsung overhauled Galaxy Watch health scoring, and Google rebranded Fitbit into “Google Health” with a Gemini-powered coach. The smart-ring and wearable category has shifted rapidly from step-and-sleep tracking toward AI-mediated health interpretation, driven partly by consumer demand for GLP-1-adjacent tracking and partly by companies looking for subscription revenue beyond hardware sales.
Oura’s own history is instructive here. The company built its brand on being the first mainstream smart ring, winning over a base of biohackers and executives who valued its discreet form factor over a watch. That early focus on sleep and recovery data gave Oura a large longitudinal dataset it can now use to train the AI features underpinning Health Radar and GLP-1 Insights — an advantage newer ring entrants like Ultrahuman are racing to match with their own on-device AI models. The Ring 5 launch also reflects competitive pressure: Samsung, Whoop, and Google all shipped rival AI health features within the same few months, making the smaller, AI-enhanced ring as much a defensive move as an innovation.
Consumers weighing whether to upgrade also face a practical question the coverage hasn’t fully resolved: Oura’s membership fee is charged on top of the ring’s purchase price, meaning the AI features driving most of this update — Health Radar, GLP-1 Insights, and the new meal tracking — sit behind an ongoing subscription rather than being unlocked permanently with the hardware. That subscription-plus-hardware model, shared across Oura, Whoop, and now Google Health, is becoming the default way wearable makers monetize AI features, a shift that changes the long-term cost calculus for anyone comparing devices purely on sticker price.
What’s next
Oura has said additional features, including expanded live-activity tracking, were scheduled to roll out through June 2026. The bigger open question is regulatory: features like blood-pressure trend insights and AI-assisted medical advice sit close to a line the FDA has scrutinized for other digital health products, and Oura’s approach of partnering with a licensed telehealth provider for the clinical layer, rather than making diagnostic claims itself, appears designed to stay on the permissible side of that line. Whether users trust an AI-interpreted ring over a doctor’s office for early warning signs will likely determine how far this category can go before it draws closer regulatory attention.
